Education
About Us
Working with TipRanks
Follow Us
Artivion (AORT)
NYSE:AORT
AORT Stock Chart & Stats
$45.91
$0.30(1.03%)
At close: 4:00 PM EST
$45.91
$0.30(1.03%)
Day’s Range― - ―
52-Week Range$21.97 - $48.04
Previous CloseN/A
Volume97.41K
Average Volume (3M)382.92K
Market Cap
$2.17B
Enterprise Value$2.25B
Total Cash (Recent Filing)$73.43M
Total Debt (Recent Filing)$261.99M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Feb 12, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding47,374,940
10 Day Avg. Volume349,216
30 Day Avg. Volume382,922
Financial Highlights & Ratios
PEG Ratio1.56
Price to Book (P/B)4.31
Price to Sales (P/S)3.07
P/FCF Ratio107.85
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue5.33
Enterprise Value/Gross Profit8.27
Enterprise Value/Ebitda49.61
Forecast
1Y Price Target
$51.71Price Target Upside12.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.11
Revenue Forecast (FY)$441.75M
Bulls Say, Bears Say
Bulls Say
Financial Guidance And PerformanceAORT's 3Q25 revenue and EBITDA beat consensus and AORT raised its 2025 revenue guidance and EBITDA guidance.
Innovation And Pipeline DevelopmentThe company continues to have a solid pipeline of potential PMA products that could drive continued growth in the stent graft business for years to come.
Product Launch And Market AdoptionThe AMDS acute type A aortic dissection repair device US launch is developing positively, with many sites adopting the system, supporting Artivion's growth.
Bears Say
Artivion News
AORT FAQ
What was Artivion’s price range in the past 12 months?
Artivion lowest stock price was $21.97 and its highest was $48.04 in the past 12 months.
What is Artivion’s market cap?
Artivion’s market cap is $2.17B.
When is Artivion’s upcoming earnings report date?
Artivion’s upcoming earnings report date is Feb 12, 2026 which is in 55 days.
How were Artivion’s earnings last quarter?
Artivion released its earnings results on Nov 06, 2025. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.017 by $0.113.
Is Artivion overvalued?
According to Wall Street analysts Artivion’s price is currently Undervalued.
Does Artivion pay dividends?
Artivion pays a Quarterly dividend of $0.03 which represents an annual dividend yield of N/A. See more information on Artivion dividends here
What is Artivion’s EPS estimate?
Artivion’s EPS estimate is 0.06.
How many shares outstanding does Artivion have?
Artivion has 47,374,940 shares outstanding.
What happened to Artivion’s price movement after its last earnings report?
Artivion reported an EPS of $0.13 in its last earnings report, beating expectations of $0.017. Following the earnings report the stock price went down -5.537%.
Which hedge fund is a major shareholder of Artivion?
Currently, no hedge funds are holding shares in AORT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Artivion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$51.71 (12.63% Upside)
$51.71 (12.63% Upside)
Blogger Sentiment
Bullish
AORT Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 781.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.52%
12-Months-Change
Fundamentals
Return on Equity
-2.45%
Trailing 12-Months
Asset Growth
6.79%
Trailing 12-Months
Company Description
Artivion
Artivion, Inc. (AORT) is a leading medical device company specializing in the development and commercialization of innovative solutions for cardiovascular surgery. The company focuses on advanced technologies for the treatment of aortic disease, mitral valve repair, and other cardiovascular conditions. Artivion's core products include a range of devices for cardiac and vascular surgeries, including stent grafts, tissue-based heart valves, and surgical adhesives that enhance surgical outcomes and improve patient care.
AORT Company Deck
AORT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter with significant revenue and EBITDA growth driven by key product lines. Positive clinical data and reimbursement updates further strengthen the company's position. However, challenges include costs related to a past cybersecurity incident and expected growth rate challenges for AMDS in 2026.View all AORT earnings summariesAORT Stock 12 Month Forecast
Average Price Target
$51.71
▲(12.63% Upside)
Technical Analysis
Ownership Overview
4.53% Insiders
31.29% Mutual Funds
28.45% Other Institutional Investors
16.30% Public Companies and
Individual Investors